CY1817A - Inhalation medicaments for treating respiratory disorders - Google Patents

Inhalation medicaments for treating respiratory disorders

Info

Publication number
CY1817A
CY1817A CY181795A CY181795A CY1817A CY 1817 A CY1817 A CY 1817A CY 181795 A CY181795 A CY 181795A CY 181795 A CY181795 A CY 181795A CY 1817 A CY1817 A CY 1817A
Authority
CY
Cyprus
Prior art keywords
respiratory disorders
treating respiratory
inhalation medicaments
medicaments
inhalation
Prior art date
Application number
CY181795A
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27264676&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1817(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB898920392A external-priority patent/GB8920392D0/en
Priority claimed from GB898923644A external-priority patent/GB8923644D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of CY1817A publication Critical patent/CY1817A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CY181795A 1989-09-08 1995-10-20 Inhalation medicaments for treating respiratory disorders CY1817A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB898920392A GB8920392D0 (en) 1989-09-08 1989-09-08 Medicaments
GB898923644A GB8923644D0 (en) 1989-10-20 1989-10-20 Medicaments
GB9019659A GB2235627B (en) 1989-09-08 1990-09-07 Inhalation medicaments for treating respiratory disorders

Publications (1)

Publication Number Publication Date
CY1817A true CY1817A (en) 1995-10-20

Family

ID=27264676

Family Applications (1)

Application Number Title Priority Date Filing Date
CY181795A CY1817A (en) 1989-09-08 1995-10-20 Inhalation medicaments for treating respiratory disorders

Country Status (2)

Country Link
CY (1) CY1817A (en)
GB (1) GB2235627B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270305A (en) 1989-09-08 1993-12-14 Glaxo Group Limited Medicaments
SK280967B6 (en) 1990-03-02 2000-10-09 Glaxo Group Limited Inhalation device
US6536427B2 (en) 1990-03-02 2003-03-25 Glaxo Group Limited Inhalation device
JP3026841B2 (en) 1991-12-12 2000-03-27 グラクソ、グループ、リミテッド Medicine
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
CA2317999C (en) 1999-09-11 2004-11-09 Glaxo Group Limited Pharmaceutical formulation of fluticasone propionate
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
GB0124523D0 (en) * 2001-10-12 2001-12-05 Glaxo Group Ltd Pharmaceutical combination
KR20060135873A (en) * 2004-03-12 2006-12-29 씨아이피엘에이 엘티디. Salmeterol inhalation formulations
CA2677838C (en) 2007-02-11 2017-08-01 Map Pharmaceuticals, Inc. Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile

Also Published As

Publication number Publication date
GB2235627A (en) 1991-03-13
GB2235627B (en) 1993-09-01
GB9019659D0 (en) 1990-10-24

Similar Documents

Publication Publication Date Title
HU9401742D0 (en) Medicaments for inhalation
DE3573729D1 (en) Medicament inhalation device
GB8924823D0 (en) Dosage inhalers
AU2250788A (en) Respiratory mask
GB9017230D0 (en) Circulatory respiratory protective apparatus
GB8706200D0 (en) Respiratory mask
IL116492A0 (en) Therapeutic preparations for inhalation
HU913680D0 (en) Inhaling apparatus, primarily for powdered medicaments
GB2264235B (en) Composition for nasal treatment
GB2235627B (en) Inhalation medicaments for treating respiratory disorders
GB2218640B (en) Medical breathing apparatus
GB8723984D0 (en) Respiratory protective apparatus
GB8911259D0 (en) Inhalation medicament
GB2234440B (en) Respiratory protective apparatus
GB2190000B (en) Inhalation therapy unit
ZA90380B (en) Circulatory respiratory protective apparatus
ZA86365B (en) Use of sulphanyldihydropyridines as medicaments for the treatment of asthma
ZA895215B (en) Respiratory apparatus
PL284056A1 (en) Inhaler for nasal inhalations
GB8914225D0 (en) Medicament inhalation device
GB8922012D0 (en) Composition for treatment of respiratory ailments
LTIP1977A (en) Therapeutic preparation for inhalation
GB8900268D0 (en) Inhalation devices having dosage control
IE883710L (en) Medicaments for the treatment of anxiety
CA71422S (en) Medicament inhalation device